terazosin

Generic: terazosin hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 10 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-2371
Product ID 50090-2371_20c2b6cd-ed1d-4eb3-a143-5151902b9c30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2027-12-31
Marketing Start 2004-12-20

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500902371
Hyphenated Format 50090-2371

Supplemental Identifiers

RxCUI
260376 313217 313219
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-2371-0)
source: ndc

Packages (1)

50090-2371-0 30 CAPSULE in 1 BOTTLE (50090-2371-0)

Ingredients (1)

terazosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "20c2b6cd-ed1d-4eb3-a143-5151902b9c30", "openfda": {"unii": ["D32S14F082"], "rxcui": ["260376", "313217", "313219"], "spl_set_id": ["83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-2371-0)", "package_ndc": "50090-2371-0", "marketing_start_date": "20181011"}], "brand_name": "Terazosin", "product_id": "50090-2371_20c2b6cd-ed1d-4eb3-a143-5151902b9c30", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "50090-2371", "generic_name": "Terazosin Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041220", "listing_expiration_date": "20271231"}